TrialClinical and vaccine immunology : CVI2007

OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine.

Christopher G Earnhart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.